<DOC>
	<DOCNO>NCT00074386</DOCNO>
	<brief_summary>With improved anti-HIV drug therapy , HIV infect patient live longer . These patient risk liver kidney failure may need organ transplant . However , little know safety effectiveness organ transplant patient HIV . This study evaluate organ transplantation HIV infect patient undergo liver kidney transplant .</brief_summary>
	<brief_title>Kidney Liver Transplantation People With HIV</brief_title>
	<detailed_description>HIV infect people significant risk end stage organ disease . Prior advent highly active antiretroviral therapy ( HAART ) , people often consider transplant candidate base concern potential adverse effect immunosuppressive drug HIV disease progression . However , use HAART , HIV infect people experience significant improvement morbidity mortality . HIV infect people end stage kidney liver disease potential candidate transplantation , yet patient clinician lack necessary data determine safety efficacy transplantation immunosuppression group . This lack conclusive data lead continued denial care many transplant center third party payer , result frustration confusion patient health care provider . This study evaluate safety efficacy solid organ transplantation people HIV infection follow prospective , multi-center cohort HIV infect people undergo kidney liver transplantation . The long-term goal : 1 ) provide patient clinicians information regard HIV-specific risk transplantation ; 2 ) provide clinician information necessary manage immunosuppressive HAART medication together ; 3 ) understand underlie basic science mechanism explain patient outcomes clinical management adjust improve outcomes . Approximately 150 kidney 125 liver transplant patient enrol study 3-year period medical research center throughout United States . Participants enrol study five year day transplant .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Inclusion Criteria All Participants : HIV infection Undetectable HIV viral load Meet eligibility requirement transplant ( requirement HIV uninfected patient must meet ) Willing take medication prevent certain infection Willing undergo frequent monitoring , include liver biopsy , treatment , participant hepatitis B C virus infection Willing submit laboratory test result within 7 day blood draw Willing notify transplant team change medication If participant history HIVrelated cancer opportunistic infection , additional eligibility criterion must meet . Inclusion Criteria Patients Undergoing Kidney Transplant : CD4 count great 200 cells/mm3 . CD4 count requirement child base child 's age . Participant use drug IL2 GMCSF order increase CD4 count 6 month prior transplant . Inclusion Criteria Patients Undergoing Liver Transplant : CD4 count great 100 cells/mm3 . CD4 count requirement child base child 's age . Some participant certain HIVrelated disease must CD4 count great 200 cells/ml 6 month prior study entry . Exclusion Criteria All Participants : Pregnancy Significant waste weight loss</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>Transplant</keyword>
	<keyword>Liver</keyword>
	<keyword>Kidney</keyword>
	<keyword>Organ</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Kidney Transplant</keyword>
	<keyword>Liver Transplant</keyword>
</DOC>